Comments

SAB Biotherapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does SAB Biotherapeutics (SABSW) operate in?

SAB Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

SABSWNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

SAB Biotherapeutics (SABSW) Forecast

News Earnings SAB Biotherapeutics (SABSW) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

SAB Biotherapeutics Stock Price, Quotes and Forecasts | NASDAQ:SABSW | Benzinga

Explore SAB Biotherapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SABSW.

Open	$0.02
Close	-
Volume / Avg.	11.54K / 5.43K
Day Range	$0.02 - $0.04
52 Wk Range	0.02 - 0.18
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	6.61

Recent News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$0.02
Close	-
Volume / Avg.	11.54K / 5.43K
Day Range	$0.02 - $0.04
52 Wk Range	0.02 - 0.18
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	6.61

About SAB Biotherapeutics Inc

Sector

Health Care

Industry

Biotechnology

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy SAB Biotherapeutics (SABSW) stock?

You can purchase shares of SAB Biotherapeutics (NASDAQ:SABSW) through any online brokerage.

View our list of the best stock brokerages

Who are SAB Biotherapeutics (SABSW) competitors?

Other companies in SAB Biotherapeutics’s space includes: BeiGene (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for SAB Biotherapeutics (SABSW) stock?

There is no analysis for SAB Biotherapeutics to provide a consensus price target.

What is the current price for SAB Biotherapeutics (SABSW)?

The stock price for SAB Biotherapeutics (NASDAQ: SABSW) is $0.0359 last updated May 23, 2025 at 2:08 PM EDT.

Does SAB Biotherapeutics (SABSW) pay a dividend?

There are no upcoming dividends for SAB Biotherapeutics.

When is SAB Biotherapeutics (NASDAQ:SABSW) reporting earnings?

SAB Biotherapeutics does not have any upcoming earnings scheduled.

Is SAB Biotherapeutics (SABSW) going to split?

There is no upcoming split for SAB Biotherapeutics.

What sector and industry does SAB Biotherapeutics (SABSW) operate in?

SAB Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.